The Nature Portfolio Bioengineering Community is a community blog for readers and authors of Nature Research journals, including Nature Biomedical Engineering, Nature Biotechnology, Nature Communications, Nature Medicine, and others. Become a member, and contribute with research news and stories.
Recent Comments
Could CRISPR be used to suppress MECP2 duplication, either pre- or post- natally?
Is there a future application for RNA therapeutics in such genetic abnormalities as MECP2 duplication; perhaps in utero?